You have 9 free searches left this month | for more free features.

Ovarian Cancer Stage III

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ctDNA Predicts Recurrence of Advanced Ovarian Cancer After

Recruiting
  • Ovarian Cancer Stage IV
  • Ovarian Cancer Stage III
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital
    Aug 30, 2023

    Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial (Artificial Intelligence)

    Not yet recruiting
    • Ovarian Cancer Stage III
    • Ovarian Cancer Stage IV
    • Artificial Intelligence
    • (no location specified)
    Aug 24, 2023

    Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3 Trial in Washington, Hackensack (NY-ESO-1 Peptide

    Not yet recruiting
    • Ovarian Cancer Stage IV
    • +2 more
    • Washington, District of Columbia
    • +2 more
    Jul 28, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (Microdevice)

    Recruiting
    • Ovarian Cancer
    • +6 more
    • Microdevice
    • Boston, Massachusetts
    • +1 more
    Jul 12, 2022

    Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

    Not yet recruiting
    • Ovarian Cancer
    • Birmingham, Alabama
      O'Neal Comprehensive Cancer Center at UAB
    Jul 18, 2023

    Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial in Seoul (Oregovomab, Bevacizumab,

    Recruiting
    • Ovarian Cancer by FIGO Stage
    • +2 more
    • Oregovomab
    • +3 more
    • Daegu, Korea, Republic of
    • +5 more
    Oct 20, 2022

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 27, 2023

    Ovarian Cancer, Ovarian Carcinoma, Ovarian Cancer Stage IV Trial in Boston (Exercise, Attention Control)

    Recruiting
    • Ovarian Cancer
    • +6 more
    • Exercise
    • Attention Control
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    May 4, 2022

    Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte

    Not yet recruiting
    • Malignant Female Reproductive System Neoplasm
    • +10 more
    • Discussion
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Mar 24, 2023

    Ovarian Cancer Trial (Huaier granule)

    Not yet recruiting
    • Ovarian Cancer
    • Huaier granule
    • (no location specified)
    Feb 28, 2023

    Ovarian Cancer Trial in Goyang (Cisplatin)

    Not yet recruiting
    • Ovarian Cancer
    • Goyang, Gyeonggi, Korea, Republic of
      National Cancer Center
    Apr 24, 2023

    Epithelial Ovarian Cancer, Ovarian Cancer, Ovarian Cancer Stage III Trial (Niraparib)

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • +3 more
    • (no location specified)
    Jan 10, 2022

    Stage III Vulvar Cancer, Stage III Ovarian Cancer, Stage III Uterine Cancer Trial in Indianapolis (Intervention group triads)

    Enrolling by invitation
    • Stage III Vulvar Cancer
    • +7 more
    • Intervention group triads
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Aug 10, 2023

    Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)

    Not yet recruiting
    • Stage III Ovarian Cancer
    • +5 more
    • (no location specified)
    Dec 12, 2022

    HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

    Active, not recruiting
    • HER2-positive Breast Cancer
    • +8 more
    • pNGVL3-hICD vaccine
    • +6 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Nov 1, 2022

    Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Sunnybrook Research Institute
    Jul 18, 2023

    Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

    Not yet recruiting
    • Advanced Fallopian Tube Carcinoma
    • +10 more
    • Wee1 Inhibitor ZN-c3
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 25, 2023

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Houston, Texas
    • +4 more
    Oct 20, 2022

    Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

    Recruiting
    • Fallopian Tube Endometrioid Adenocarcinoma
    • +17 more
    • Biopsy
    • +3 more
    • Augusta, Georgia
    • +4 more
    Jan 25, 2023

    Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Breast Cancer Stage IV Trial in Pittsburgh (Strong Together serious game)

    Completed
    • Ovarian Cancer Stage III
    • +12 more
    • Strong Together serious game
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Dec 14, 2021

    Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

    Recruiting
    • Advanced Fallopian Tube Carcinoma
    • +21 more
    • Biopsy
    • +2 more
    • Bethesda, Maryland
    • +2 more
    Jan 25, 2023

    Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

    Recruiting
    • Fallopian Tube Endometrioid Adenocarcinoma
    • +32 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 16, 2022

    FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer

    Completed
    • FIGO Stage III and IV Ovarian Cancer
    • +2 more
    • ALT-803 Subcutaneous
    • ALT-803 Intraperitoneal
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Oct 5, 2022

    Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

    Recruiting
    • Advanced Pancreatic Carcinoma
    • +27 more
    • Gainesville, Florida
    • +3 more
    Jan 3, 2023

    Ovarian Cancer, Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial in Prague (other, behavioral, dietary supplement)

    Recruiting
    • Ovarian Cancer
    • +4 more
    • Physiological intervention
    • +2 more
    • Prague, Czechia
      Gynecologic Oncology Center in Prague
    Mar 29, 2022